Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06375733
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2024-03-05
Brief Title:
A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
Sponsor:
Zhejiang Genfleet Therapeutics Co Ltd
Organization:
Genfleet Therapeutics Shanghai Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-20
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-05
First Submit QC Date:
April 16 2024
Study First Post Date:
2024-04-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-16
Last Update Post Date:
2024-04-19
Last Update Post Date Type:
ACTUAL